RESUMO
Acute generalized exanthematous pustulosis (AGEP) is a severe adverse cutaneous drug reaction. Although an involvement of drug-specific T cells has been reported, the physiopathology of AGEP and mechanism of neutrophilic skin inflammation remain incompletely understood. Recently, mutations in IL-36RN, the gene encoding the IL-36 receptor antagonist, have been reported to be more frequent in AGEP patients and pustular psoriasis. Here, we show that IL-36 cytokines, in particular IL-36γ, are highly expressed in lesional skin of AGEP patients, keratinocytes and macrophages being a major source of IL-36γ. Such an IL-36γ overexpression was not observed in patients with drug-induced maculopapular rash. In vitro, the causative drug specifically induced IL-36γ release either directly by the patient's peripheral blood monocytes or indirectly by keratinocytes in the presence of autologous peripheral blood mononuclear cells. Such culprit drug induction of IL-36γ secretion in vitro was specific for AGEP and involved toll-like receptor 4 sensing the drug/albumin complex as a danger signal. Our results suggest that IL-36γ secretion by monocytes/macrophages and keratinocytes in response to culprit drug exposure likely plays a key role in the pathogenesis of AGEP.
Assuntos
Pustulose Exantematosa Aguda Generalizada/genética , Regulação da Expressão Gênica , Interleucina-1/genética , Leucócitos Mononucleares/patologia , RNA/genética , Pele/patologia , Pustulose Exantematosa Aguda Generalizada/metabolismo , Pustulose Exantematosa Aguda Generalizada/patologia , Humanos , Interleucina-1/biossíntese , Queratinócitos/metabolismo , Queratinócitos/patologia , Leucócitos Mononucleares/metabolismo , Pele/metabolismoRESUMO
BACKGROUND: Pustular skin disorders are a category of difficult-to-treat and potentially life-threatening conditions that involve the appearance of neutrophil-rich pustules. The molecular basis of most pustular skin conditions has remained unknown. OBJECTIVE: We sought to investigate the molecular basis of 3 pustular skin disorders: generalized pustular psoriasis (GPP), palmoplantar pustulosis (PPP), and acute generalized exanthematous pustulosis (AGEP). METHODS: Microarray analyses were performed to profile genome-wide gene expression of skin biopsy specimens obtained from patients with GPP, PPP, or AGEP and healthy control subjects. Functional enrichment, gene network, and k-means clustering analyses were used to identify molecular pathways dysregulated in patients with these disorders. Immunohistochemistry and immunofluorescence were used to determine protein localization. Quantitative RT-PCR and ELISA were used to determine transcript and secreted cytokine levels. Small interfering RNA was used to decrease transcript levels. RESULTS: Molecules and pathways related to neutrophil chemotaxis emerged as common alterations in patients with GPP, PPP, and AGEP, which is consistent with the pustular phenotypes. Expression of two 6-transmembrane epithelial antigens of the prostate (STEAP) proteins, STEAP1 and STEAP4, was increased in patients' skin and colocalized with IL-36γ around neutrophilic pustules. STEAP1/4 expression clustered with and positively correlated with that of IL-1, the IL-36 family proteins, and CXCL1/8. STEAP4 expression was activated by cytokines and suppressed by inhibition of mitogen-activated protein kinase kinase 1/2, whereas STEAP1 expression appeared less prone to such dynamic regulation. Importantly, STEAP1/4 knockdown resulted in impaired induction of a broad spectrum of proinflammatory cytokines, including IL-1, IL-36, and the neutrophil chemotaxins CXCL1 and CXCL8. STEAP1/4 knockdown also reduced the ability of keratinocytes to induce neutrophil chemotaxis. CONCLUSION: Transcriptomic changes in 3 pustular skin disorders, GPP, PPP, and AGEP, converged on neutrophil chemotaxis and diapedesis and cytokines known to drive neutrophil-rich inflammatory processes, including IL-1 and members of the IL-36 family. STEAP1 and STEAP4 positively regulate the induction of proinflammatory neutrophil-activating cytokines.
Assuntos
Pustulose Exantematosa Aguda Generalizada/metabolismo , Antígenos de Neoplasias/biossíntese , Proteínas de Membrana/biossíntese , Oxirredutases/biossíntese , Psoríase/metabolismo , Quimiotaxia de Leucócito/fisiologia , Análise por Conglomerados , Ensaio de Imunoadsorção Enzimática , Técnicas de Silenciamento de Genes , Humanos , Imuno-Histoquímica , Inflamação/metabolismo , Interleucina-1/biossíntese , Neutrófilos/metabolismo , Análise de Sequência com Séries de Oligonucleotídeos , Reação em Cadeia da Polimerase , TranscriptomaRESUMO
BACKGROUND: Few studies have been published on the histopathology of cutaneous adverse drug reactions (CADR), and most of these lack information on skin allergological tests. The histopathology of drug reaction with eosinophilia and systemic symptoms (DRESS) is also seldom described. The purpose of our study was to examine six types of well-documented CADR (maculopapular exanthema, DRESS, fixed drug eruption, Stevens-Johnson syndrome, toxic epidermal necrolysis [TEN], and acute generalized exanthematous pustulosis) using histopathology and immunohistochemistry to evaluate the expression of granulysin, a key molecule in TEN. METHODS: We retrospectively included 106 skin biopsies performed in proven cases of CADR (by chronological investigation, single attributable drug, or/and skin tests). All slides were reviewed, and microscopic changes were analyzed using a standardized form. Granulysin expression was studied by immunohistochemistry. RESULTS: In DRESS, we observed spongiosis, edema, and basal vacuolization, with rare necrotic keratinocytes and constant lymphocytic infiltrate in the superficial dermis. Eosinophils were often present, and pustules were found in 15% of cases. Necrotic keratinocytes are often absent in maculopapular exanthema. Granulysin was expressed in six types of CADR with a trend toward more intense expression in DRESS and TEN. CONCLUSION: We detailed further about the histopathology of DRESS. Granulysin expression was observed in all CADR with a marked overlap of expression pattern between the six types.
Assuntos
Antígenos de Diferenciação de Linfócitos T/análise , Toxidermias/metabolismo , Toxidermias/patologia , Pele/química , Pele/patologia , Pustulose Exantematosa Aguda Generalizada/metabolismo , Pustulose Exantematosa Aguda Generalizada/patologia , Adulto , Idoso , Biópsia , Síndrome de Hipersensibilidade a Medicamentos/metabolismo , Síndrome de Hipersensibilidade a Medicamentos/patologia , Feminino , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Síndrome de Stevens-Johnson/metabolismo , Síndrome de Stevens-Johnson/patologiaRESUMO
Acute generalized exanthematous pustulosis (AGEP) and generalized pustular psoriasis (GPP) are rare pustular skin disorders with systemic involvement. IL-17A/F is a proinflammatory cytokine involved in various neutrophilic inflammatory disorders. Here we show that IL-17A/F is highly expressed by innate immune cells such as neutrophils and mast cells in both AGEP and GPP.
Assuntos
Pustulose Exantematosa Aguda Generalizada/metabolismo , Imunidade Inata , Mediadores da Inflamação/metabolismo , Interleucina-17/metabolismo , Mastócitos/metabolismo , Neutrófilos/metabolismo , Psoríase/metabolismo , Pele/metabolismo , Pustulose Exantematosa Aguda Generalizada/genética , Pustulose Exantematosa Aguda Generalizada/imunologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Feminino , Humanos , Mediadores da Inflamação/imunologia , Interleucina-17/genética , Interleucina-17/imunologia , Masculino , Mastócitos/imunologia , Pessoa de Meia-Idade , Neutrófilos/imunologia , Psoríase/genética , Psoríase/imunologia , RNA Mensageiro/metabolismo , Transdução de Sinais , Pele/imunologia , Adulto JovemAssuntos
Pustulose Exantematosa Aguda Generalizada/imunologia , Haptenos/imunologia , Células Th17/imunologia , beta-Lactamas/imunologia , Pustulose Exantematosa Aguda Generalizada/diagnóstico , Pustulose Exantematosa Aguda Generalizada/metabolismo , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Células Th17/metabolismoAssuntos
Pustulose Exantematosa Aguda Generalizada/patologia , Antibacterianos/efeitos adversos , Clindamicina/efeitos adversos , Toxidermias/patologia , Ofloxacino/efeitos adversos , Pele/patologia , Pustulose Exantematosa Aguda Generalizada/induzido quimicamente , Pustulose Exantematosa Aguda Generalizada/imunologia , Pustulose Exantematosa Aguda Generalizada/metabolismo , Idoso , Biomarcadores/análise , Biópsia , Toxidermias/etiologia , Toxidermias/imunologia , Toxidermias/metabolismo , Feminino , Humanos , Imuno-Histoquímica , Testes do Emplastro , Valor Preditivo dos Testes , Pele/química , Pele/efeitos dos fármacos , Pele/imunologiaRESUMO
In some adverse drug reactions (ADRs), genetic predisposition plays a significant role in pathogenesis, and the skin is the most frequently reported target. These severe cutaneous ADRs include bullous fixed drug eruptions (FDE), acute generalized exanthematous pustulosis (AGEP), drug-induced hypersensitivity syndrome (HSS), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). The putative contribution of individual effector cells in drug hypersensitivity is briefly mentioned. To trigger these drug hypersensitivities, certain class I HLA alleles (e.g., HLA-A and HLA-B alleles) and certain class II HLA alleles (e.g., HLA-DR alleles) have been recently found to be the genetic determinants. One of the best characterized examples mentioned in this article is HLA-B*1502 to determine the incidence of carbamazepine-induced SJS. How drugs are processed and presented by these HLA alleles to activate immune responses has been explained by several hypotheses. Further implication of pharmagenomic findings to prevent drug-induced severe skin reactions can be achieved by pre-screening putative risk HLA alleles before using drugs.
Assuntos
Toxidermias/genética , Toxidermias/metabolismo , Antígenos HLA/genética , Antígenos HLA/metabolismo , Queratinócitos/efeitos dos fármacos , Farmacogenética/métodos , Polimorfismo Genético , Pustulose Exantematosa Aguda Generalizada/induzido quimicamente , Pustulose Exantematosa Aguda Generalizada/genética , Pustulose Exantematosa Aguda Generalizada/metabolismo , Pustulose Exantematosa Aguda Generalizada/prevenção & controle , Toxidermias/imunologia , Toxidermias/prevenção & controle , Humanos , Queratinócitos/imunologia , Queratinócitos/metabolismo , Queratinócitos/patologia , Índice de Gravidade de Doença , Síndrome de Stevens-Johnson/induzido quimicamente , Síndrome de Stevens-Johnson/genética , Síndrome de Stevens-Johnson/imunologia , Síndrome de Stevens-Johnson/metabolismo , Síndrome de Stevens-Johnson/prevenção & controleRESUMO
Ki-67 is an established marker of cell proliferation. It is highly expressed in psoriasis and correlated with the clinical severity of psoriasis. Higher number of Ki-67 positive keratinocytes has been observed in pustular psoriasis (PP) as compared with psoriasis vulgaris. As for Acute generalized exanthematous pustulosis (AGEP), a distinct disease entity but similar in many aspects of clinicopathologic features to PP, Ki-67 immunostaining presentation has never been investigated before. This study aimed to compare Ki-67 immunostaining presentation between PP and AGEP. By immunohistochemical staining, we compared Ki-67 immunostaining presentation on skin lesions of five patients of AGEP and five age-matched patients of PP. Ki-67 positive keratinocytes were counted and mean values were determined to compare between PP and AGEP. An augmented presence of Ki-67 positive keratinocytes was found in both AGEP and PP and they distributed not only in basal cell layer but in middle or even upper part of epidermis. Statistical analysis using Mann-Whitney U test showed no difference of epidermal proliferation rate between the two groups (P = 0.222). The results showed there was no difference of Ki-67 immunostaining presentation between AGEP and PP. Besides, we found marked increase of Ki-67-positive proliferating keratinocytes in AGEP and suggested that epidermal hyperproliferation may also play an important role in the formation of AGEP. We also discussed the possible pathophysiology of AGEP, possible epidermal architecture changes in AGEP and PP, and found the similarity in pathophysiology of AGEP and PP.